Loading…
← CockpitCompetitor Analysis › GMRS GMR Solutions, Inc. Class AOpen in the cockpit ↗

GMR Solutions, Inc. Class AGMRSCompetitor analysis, valuation and peers

United States · USD·Health Care›Medical/Nursing Services
Momentum weak 35
Mkt cap
$714M
US dollars, full cap
Free float
65%
of shares outstanding
$/day
$13.3M
20-day average traded
Fwd P/E
5.9×
forward earnings
ROIC−WACC
+7.0 pp
WACC 5.7%
Hurdle
-16 pp
Req g minus delivered
Next earnings
105 days
3 Mar 2027
Close · USD$10.71
1D-4.3%
1W-8.9%
1M+2.2%
3M-24.3%
6M-8.3%
YTDn/a
1Yn/a
ATR %7.6%
52w lowhigh33.0% off high

What GMR Solutions does

Employees: 33,858

GMR Solutions at a glance

Size GMR Solutions (GMRS) is a United States Health Care company (Medical/Nursing Services) with a market value of $714M, the 2447th largest of 3,085 United States companies the cockpit tracks. Shares closed at $10.71 on 18 Nov 2026.

Performance Over six months the shares fell 8.3%, against -1.8% for the median peer and -2.2% for the United States market (cap-weighted) — 10th lowest of 21 in its peer set.

Growth Revenue fell 4.0% over the last twelve months (peer median +6.2%); the operating margin is 14.4% (peer median 7.5%).

Valuation It trades at 5.9× forward earnings against a peer median of 19.8× (cheapest of 16).

Price implies For today's price to make sense, revenue must grow about -20% a year for seven years (Req g). Recent delivered growth is -4%, so the hurdle is -16 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 7.0 points above its cost of capital (5.7% WACC).

Short interest Short interest is 8.7% of the free float (30 Oct 2026).

Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).

Relative performance

8010012014021 May 202621 Aug 202618 Nov 2026Peer median 101GMRS 95
Six months, rebased to 100: GMR Solutions against the median of its 20 peers (local-currency closes).

GMR Solutions financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023
Revenuen/a$5.74B$5.98B$5.39B
Revenue growth—-4%+11%—
Gross profitn/a$1.90B$2.14B$1.76B
EBITDAn/a$1.15B$1.02B$736M
Net incomen/a$206M$20.4M-$203M
Free cash flown/a$383M-$22.4M$86.7M
Capital expendituren/a$259M$269M$171M
Total debt$4.60B$5.37B$4.86Bn/a

Quarterly statements and history in the cockpit →

GMR Solutions competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%+40%-20%0%+20%NEPHROPLUSFLGT1951WELL195940TTALOTHYROCARE4694DNAREG301060AHCO688315127120GDRXSRTANUTXACLIDXMETROPOLISGMRS6-month return →1-month return →
Up and to the right = strong over both horizons. GMR Solutions is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%0×25×50×75×NEPHROPLUS1951WELL195940TTALOTHYROCARE4694REG688315GDRXSRTANUTXIDXMETROPOLISGMRSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. GMR Solutions is the large dot.

Capital: growth delivered against growth the price implies

0%+100%+200%0%100%200%NEPHROPLUS1951WELL195940TTALOTHYROCARE301060NUTXGMRSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. GMR Solutions is the large dot.

GMR Solutions competitors and peer comparison

How GMR Solutions compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

GMR Solutions against its 20 peers (data as of 18 Nov 2026)
MeasureGMRSPeer medianRank in peer set
1-month return+2.2%+1.0%10th highest of 21
6-month return-8.3%-1.8%10th lowest of 21
Distance from 52-week high-33.0%-25.8%9th lowest of 21
Revenue growth (TTM)-4.0%+6.2%5th lowest of 21
Operating margin14.4%7.5%4th highest of 21
Forward P/E5.9×19.8×cheapest of 16
Growth the price implies (Req g, 7 yrs)-19.6%8.9%least demanding of 17
Growth delivered (Del g)-4.0%+11.5%lowest of 17
Hurdle (Req g minus delivered)-15.7 pp-1.2 pp4th least demanding of 17
ROIC minus cost of capital+7.0 pp-0.3 pp4th highest of 20
EV / EBITDA4.3×8.0×2nd cheapest of 15
Net debt / EBITDA3.7×1.3×2nd most indebted of 16

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
GMR Solutions GMRSUnited States$714M-8%-4%14%5.9×-19.6%-4.0%
Nephrocare Health Services NEPHROPLUS.NSIndia$702M+1%+33%13%48.8×36.6%+31.6%
Fulgent Genetics FLGTUnited States$702M+53%+5%-38%n/an/an/a
Jinxin Fertility 1951.HKHong Kong$758M-4%+7%11%23.1×17.8%+12.4%
WELL Health Technologies WELL.TOCanada$661M-9%+29%6%10.1×10.1%+94.5%
HK inno.N 195940.KSSouth Korea$783M-28%+7%12%12.3×-4.7%+12.2%
Terveystalo Oy TTALO.HEFinland$832M-26%-8%8%10.7×-5.1%+5.3%
Thyrocare Technologies THYROCARE.NSIndia$858M+7%+22%26%36.0×28.5%+10.9%
BML 4694.TJapan$932M+12%+4%7%19.8×-9.0%+1.6%
Ginkgo Bioworks DNAUnited States$547M+9%-44%-242%n/an/an/a
Regis Healthcare REG.AXAustralia$962M-28%+17%4%25.3×13.3%+14.4%
Shanghai Labway Clinical Laboratory 301060.SZChina$518M-17%-19%6%n/a5.9%+3.2%
AdaptHealth AHCOUnited States$1.01B-30%-3%3%n/a16.8%+25.2%
Novogene 688315.SSChina$1.01B+13%+6%7%44.8×13.9%+8.2%
JS Link 127120.KSSouth Korea$458M-62%+39%-83%n/an/an/a
GoodRx GDRXUnited States$1.15B+33%-2%12%10.6×6.3%+7.7%
Strata Critical Medical SRTAUnited States$443M-10%+23%-4%86.3×n/an/a
Nutex Health NUTXUnited States$1.19B+42%-19%39%6.5×-18.0%+253.5%
Australian Clinical Labs ACL.AXAustralia$418M+68%-1%8%17.8×4.3%+2.6%
Integral Diagnostics IDX.AXAustralia$413M-22%+26%9%14.7×7.8%+17.7%
Metropolis Healthcare METROPOLIS.NSIndia$1.25B+11%+20%18%44.5×32.4%+10.5%

Questions

Which companies are GMR Solutions's closest peers?
The cockpit's peer set: Nephrocare Health Services (NEPHROPLUS.NS), Fulgent Genetics (FLGT), Jinxin Fertility (1951.HK), WELL Health Technologies (WELL.TO), HK inno.N (195940.KS), Terveystalo Oy (TTALO.HE), Thyrocare Technologies (THYROCARE.NS), BML (4694.T).
Is GMR Solutions expensive compared with its peers?
On forward p/e it trades at 5.9× against a peer median of 19.8×, cheapest of 16 in its peer set. For today's price to make sense, revenue must grow about -20% a year for seven years (Req g). Recent delivered growth is -4%, so the hurdle is -16 pp: the price already allows for a slowdown.
How has GMR Solutions stock performed?
Over six months to 18 Nov 2026 the shares returned -8.3% against -1.8% for the median peer.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.